Wender: Mammography Guidelines Should Balance Benefits and Risks, Not Costs

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A controversial study on the costs of unnecessary mammography, published in the April issue of Health Affairs, contains “serious methodological flaws,” said Richard Wender, chief cancer control officer at the American Cancer Society.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Two years ago, Dan Theodorescu made a discovery that could alter biology textbooks: The Y chromosome, widely considered to be a “functional wasteland,” has functions beyond sex determination—and in fact plays a role in cancer biology. 
Matthew Bin Han Ong
Matthew Bin Han Ong

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login